- Home
- KYNB vs FTHM Comparison
KYNB vs FTHM Comparison
Compare KYNB & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KYNB | FTHM |
|---|---|---|
| Founded | 1993 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.8M | 28.8M |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KYNB | FTHM |
|---|---|---|
| Price | $7.87 | $0.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 22.1K | ★ 82.7K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9552.08 | 32.71 |
| EPS | N/A | ★ N/A |
| Revenue | $6,440,000.00 | ★ $420,477,000.00 |
| Revenue This Year | N/A | $11.67 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 25.45 |
| 52 Week Low | $6.32 | $0.40 |
| 52 Week High | $9.58 | $3.37 |
Technical Indicators
Market Signals| Indicator | KYNB | FTHM |
|---|---|---|
| Relative Strength Index (RSI) | 49.90 | 32.52 |
| Support Level | $7.40 | $0.57 |
| Resistance Level | $7.95 | $0.71 |
| Average True Range (ATR) | 0.40 | 0.04 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 45.43 | 7.84 |
Price Performance
Historical ComparisonAbout KYNB Kyntra Bio Inc. Common Stock
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, and Software as a Service (SaaS) offerings to brokerages and agents by leveraging intelliAgent , proprietary cloud-based software. The Company's three operating and reportable segments: Real Estate Brokerage, Mortgage, and Title. The majority of revenue is from Real Estate Brokerage, which provides real estate brokerage services.